ES8501984A1 - Procedimiento de perfusion perfeccionado - Google Patents
Procedimiento de perfusion perfeccionadoInfo
- Publication number
- ES8501984A1 ES8501984A1 ES523790A ES523790A ES8501984A1 ES 8501984 A1 ES8501984 A1 ES 8501984A1 ES 523790 A ES523790 A ES 523790A ES 523790 A ES523790 A ES 523790A ES 8501984 A1 ES8501984 A1 ES 8501984A1
- Authority
- ES
- Spain
- Prior art keywords
- plasma
- tumor specific
- specific antibody
- drug infusion
- immobilized protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
- A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- External Artificial Organs (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
PROCEDIMIENTO PARA LA PERFUSION EXTRACORPOREA DE PLASMA SOBRE UNA PROTEINA A INMOVILIZADA TERAPEUTICA (ESTAFILOCOCCICA) SPA.CONSISTE EN PERFUNDIR PLASMA SOBRE LA PROTEINA A PROCEDENTE DEL STAPHYLOCOCCUS AUREUS COWAN 1 (SPA) INMOVILIZADA, DE TAL MANERA QUE LA CANTIDAD DE SPA OSCILE ENTRE 0,1 Y 5,0 MG PARA ADULTOS Y ENTRE 0,001 Y 0,01 MG PARA NIN/OS. EL VOLUMEN DE PLASMA PERFUNDIDO SOBRE LA SPA OSCILA ENTRE 5 Y 300 ML PARA ADULTOS Y ENTRE 5 Y 50 ML PARA NIN/OS. EL CAUDAL DE PLASMA OSCILA ENTRE 2 Y 5 ML/MINUTO PARA ADULTOS Y PARA NIN/OS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32332681A | 1981-11-06 | 1981-11-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES523790A0 ES523790A0 (es) | 1984-12-16 |
ES8501984A1 true ES8501984A1 (es) | 1984-12-16 |
Family
ID=23258717
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES517174A Granted ES517174A0 (es) | 1981-11-06 | 1982-11-05 | Un inmunoadsorbente terapeutico. |
ES523790A Expired ES8501984A1 (es) | 1981-11-06 | 1983-07-01 | Procedimiento de perfusion perfeccionado |
ES523791A Granted ES523791A0 (es) | 1981-11-06 | 1983-07-01 | Sistema de perfusion perfeccionado |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES517174A Granted ES517174A0 (es) | 1981-11-06 | 1982-11-05 | Un inmunoadsorbente terapeutico. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES523791A Granted ES523791A0 (es) | 1981-11-06 | 1983-07-01 | Sistema de perfusion perfeccionado |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0079221A3 (es) |
JP (1) | JPS5886168A (es) |
KR (1) | KR840002244A (es) |
AU (1) | AU570911B2 (es) |
CA (1) | CA1197460A (es) |
DK (1) | DK487382A (es) |
ES (3) | ES517174A0 (es) |
FI (1) | FI823761L (es) |
IL (1) | IL66959A0 (es) |
NO (1) | NO823672L (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60120821A (ja) * | 1983-12-05 | 1985-06-28 | Asahi Chem Ind Co Ltd | 悪性腫瘍治療用白血球刺激材および刺激方法 |
DE3422435A1 (de) * | 1984-06-16 | 1986-01-16 | B. Braun Melsungen Ag, 3508 Melsungen | Verfahren und vorrichtung zur selektiven abtrennung pathologischer und/oder toxischer spezies aus blut oder blutplasma unter verwendung von filterkerzen |
US4704366A (en) * | 1984-06-22 | 1987-11-03 | Bio-Rad Laboratories, Inc. | Process for binding IgG to protein A |
US4614513A (en) * | 1984-08-13 | 1986-09-30 | Fred Hutchinson Cancer Research Center | Method and apparatus for treatment to remove immunoreactive substances from blood |
US5122112A (en) * | 1986-11-21 | 1992-06-16 | Imre Corporation | Antigen-specific removal of circulating immune complexes |
SE8801426D0 (sv) * | 1988-04-15 | 1988-04-15 | Ulf Rothman | Forfarande och medel for blodbehandling |
-
1982
- 1982-10-07 AU AU89189/82A patent/AU570911B2/en not_active Ceased
- 1982-10-11 IL IL66959A patent/IL66959A0/xx unknown
- 1982-11-03 FI FI823761A patent/FI823761L/fi not_active Application Discontinuation
- 1982-11-03 DK DK487382A patent/DK487382A/da not_active Application Discontinuation
- 1982-11-04 NO NO823672A patent/NO823672L/no unknown
- 1982-11-05 CA CA000415005A patent/CA1197460A/en not_active Expired
- 1982-11-05 EP EP82305913A patent/EP0079221A3/en not_active Withdrawn
- 1982-11-05 ES ES517174A patent/ES517174A0/es active Granted
- 1982-11-06 KR KR1019820005015A patent/KR840002244A/ko unknown
- 1982-11-06 JP JP57195196A patent/JPS5886168A/ja active Pending
-
1983
- 1983-07-01 ES ES523790A patent/ES8501984A1/es not_active Expired
- 1983-07-01 ES ES523791A patent/ES523791A0/es active Granted
Also Published As
Publication number | Publication date |
---|---|
ES8503202A1 (es) | 1984-12-16 |
AU570911B2 (en) | 1988-03-31 |
ES523790A0 (es) | 1984-12-16 |
NO823672L (no) | 1983-05-09 |
EP0079221A2 (en) | 1983-05-18 |
JPS5886168A (ja) | 1983-05-23 |
CA1197460A (en) | 1985-12-03 |
KR840002244A (ko) | 1984-06-25 |
ES8402506A1 (es) | 1983-12-01 |
FI823761A0 (fi) | 1982-11-03 |
ES517174A0 (es) | 1983-12-01 |
EP0079221A3 (en) | 1986-01-22 |
AU8918982A (en) | 1985-02-07 |
ES523791A0 (es) | 1984-12-16 |
FI823761L (fi) | 1983-05-07 |
DK487382A (da) | 1983-05-07 |
IL66959A0 (en) | 1983-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Winston et al. | Pneumococcal vaccination of recipients of bone marrow transplants | |
GB1518121A (en) | Agent for intravascular administration | |
HUP0202779A2 (hu) | Immunológiai eljárás szöveti transzglutamináz (tTG) elleni antitestek kimutatására, tTG alkalmazása diagnosztikai célokra és terápiás ellenőrzésre, valamint tTG-t tartalmazó orális gyógyászati hatóanyag | |
Pritchard et al. | MACROPHAGE-ELECTROPHORETIC-MOBILITY (MEM) TEST FOR MALIGNANT DISEASE: An Independent Confirmation | |
Reichman et al. | Measurement of hepatic blood flow by indicator dilution techniques | |
Vitetta et al. | Release of cell surface immunoglobulin by mouse splenic lymphocytes | |
Dignam et al. | Renal function in human pregnancy. I. Changes in glomerular filtration rate and renal plasma flow | |
ES8501984A1 (es) | Procedimiento de perfusion perfeccionado | |
Schenkein et al. | Specific removal of in vivo antibody by extracorporeal circulation over an immunoadsorbent in gel | |
Schofield et al. | Leucopenia and fever in the" Jarisch-Herxheimer" reaction of louse-borne relapsing fever | |
Hulme et al. | Retention and storage sites of radioactive polyvinylpyrrolidone | |
Denekamp | Cytotoxicity and radiosensitization in mouse and man | |
Granstein et al. | Necrotizing vasculitis within cutaneous lesions of mycosis fungoides | |
Yamaoka et al. | The antitumor effects of human lymphoblastoid interferon on human renal cell carcinoma in athymic nude mice | |
RU2032424C1 (ru) | Способ лечения лучевой лейкопении | |
Croughs et al. | The Effect of Insulin Binding Antibodies on Insulin-131I Metabolism | |
Bertram et al. | Staphylococcal protein A immunoadsorptive column induces mitogenicity in perfused plasma | |
Barth et al. | A radioisotopic microassay for lymphotoxin using technetium-99 labeled cells | |
GB2314334A (en) | Improved production of antibodies through the use of antigen antibody complexes | |
SU1170348A1 (ru) | Способ определени индивидуальной чувствительности организма на введение коклюшной вакцины | |
Conroy et al. | Effect of acute and chronic misonidazole administration on peripheral-nerve electrophysiology in mice | |
RU2108806C1 (ru) | Способ коррекции иммунной системы | |
Engeset et al. | STUDIES ON HUMAN PERIPHERAL LYMPH III. LEG LYMPHOGRAPHY AND SUBSEQUENT CANNULATION ON THE LYMPH VESSEL | |
Wrigley et al. | Normal cerebral function with bilateral carotid occlusion. | |
Ludens et al. | Effect of WY-5256 on renal hemodynamics |